Results 11 to 20 of about 106,976 (407)
Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications [PDF]
amiajnl-2022-012337.R1, 2022 Understanding public discourse on emergency use of unproven therapeutics is crucial for monitoring safe use and combating misinformation. We developed a natural language processing-based pipeline to comprehend public perceptions of and stances on coronavirus disease 2019 (COVID-19)-related drugs on Twitter over time.
arxiv +1 more source
Clinical Infectious Diseases, 2020 Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection.
Xueting Yao +14 more
semanticscholar +1 more source
Hydroxychloroquine and Antimalarials [PDF]
The Journal of Rheumatology, 2019 We read the editorial by Sandhu, et al1 about antimalarial-induced cardiomyopathy in systemic lupus erythematosus2, and we want to point out some inaccuracies in the brief review of the history of antimalarials that they presented.
LUIS CAMINAL-MONTERO +1 more
openaire +3 more sources
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
New England Journal of Medicine, 2020 Background Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. Methods We examined the association between hydroxychloroquine use and intubation or death at a large medical center in New ...
J. Geleris +11 more
semanticscholar +1 more source
BMC Infectious Diseases, 2021 Background Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective ...
Andrew Ip +24 more
doaj +1 more source
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
New England Journal of Medicine, 2020 Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine.
D. Boulware +23 more
semanticscholar +1 more source
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
, 2020 On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +1 more source
Hydroxychloroquine-related hyperpigmentation
Rheumatology, 2021 International ...
Muller, Romain +2 more
openaire +4 more sources
Cell Discovery, 2020 Dear Editor, The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/2019-nCoV) poses a serious threat to global public health and local economies.
Jia Liu +9 more
semanticscholar +1 more source
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Arthritis & Rheumatology, 2020 ObjectiveIn 2016, the American Academy of Ophthalmology (AAO) changed the recommended daily dose of hydroxychloroquine (HCQ) from 6.5 mg/kg to <5 mg/kg. However, it is not clear that the lower prescribed dose of HCQ will have the same efficacy for systemic lupus erythematosus (SLE) activity or the same role in protecting against cardiovascular risk ...
Michelle Petri +4 more
openaire +4 more sources